Loading clinical trials...

COMPLETEDPhase 3NCT01335061

Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B

The purpose of this study will be to determine if a once-weekly prophylaxis regimen of BeneFIX in subjects with moderately severe to severe Hemophilia B is safe and effective.

Lead sponsor: Pfizer•17 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 1

ATHNdataset Registry

NCT06820515 · Hemophilia, Thrombosis, and more

RECRUITINGPhase 1/2

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

NCT06379789 · Hemophilia B

RECRUITING

An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B

NCT06008938 · Hemophilia B

RECRUITING

National Longitudinal Cohort of Hematological Diseases

NCT04645199 · Multiple Myeloma, Acute Myeloid Leukemia, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 8, 2015Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment25

Start dateSep 2011

Last updatedJun 8, 2015

Condition

Hemophilia B

Locations shown

UMBAL Sveti Georgi, Klinika po hematologia

Plovdiv

The Ottawa Hospital

Ottawa, Ontario

University Hospital Center Zagreb

Zagreb

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 8, 2015Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions